These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 389502)

  • 1. Bleeding in renal failure: a possible role of vascular prostacyclin (PGI2).
    Remuzzi G; Marchesi D; Cavenaghi AE; Livio M; Donati MB; de Gaetano G; Mecca G
    Clin Nephrol; 1979 Sep; 12(3):127-31. PubMed ID: 389502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular factors in the pathogenesis of uraemic bleeding.
    Remuzzi G; Bertani T; Livio M; Cavenaghi AE; Mysliwiec M; Marchesi D; Donati MC; de Gaetano G; Mecca G
    Proc Eur Dial Transplant Assoc; 1978; 15():449-55. PubMed ID: 368787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostacyclin and thromboxane in chronic uremia: effect of hemodialysis.
    Ylikorkala O; Huttunen K; Järvi J; Viinikka L
    Clin Nephrol; 1982 Aug; 18(2):83-7. PubMed ID: 6754193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostacyclin-like activity and bleeding in renal failure.
    Remuzzi G; Cavenaghi AE; Mecca G; Donati MB; de Gaetano G
    Lancet; 1977 Dec; 2(8050):1195-7. PubMed ID: 73900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for an increased generation of prostacyclin in the microvasculature and an impairment of the platelet alpha-granule release in chronic renal failure.
    Kyrle PA; Stockenhuber F; Brenner B; Gössinger H; Korninger C; Pabinger I; Sunder-Plassmann G; Balcke P; Lechner K
    Thromb Haemost; 1988 Oct; 60(2):205-8. PubMed ID: 2975407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased production of prostacyclin after injury to the microvasculature in uraemic patients.
    Slazus W
    S Afr Med J; 1992 Mar; 81(6):315-7. PubMed ID: 1570581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unbalanced prostaglandin synthesis and plasma factors in uraemic bleeding. A hypothesis.
    Remuzzi G; Livio M; Cavenaghi AE; Marchesi D; Mecca G; Donati MB; de Gaetano G
    Thromb Res; 1978 Sep; 13(3):531-6. PubMed ID: 369029
    [No Abstract]   [Full Text] [Related]  

  • 8. Prolonged bleeding time and increased vascular prostacyclin in rats with chronic renal failure: effects of conjugated estrogens.
    Zoja C; Viganò G; Bergamelli A; Benigni A; de Gaetano G; Remuzzi G
    J Lab Clin Med; 1988 Sep; 112(3):380-6. PubMed ID: 2842417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced prostacyclin availability of blood vessels in uraemic humans and rats.
    Leithner C; Winter M; Silbauer K; Wagner O; Pinggera W; Sinzinger H
    Proc Eur Dial Transplant Assoc; 1978; 15():418-23. PubMed ID: 368786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal platelet and vascular prostaglandin synthesis in an infant with hemolytic uremic syndrome.
    Stuart MJ; Spitzer RE; Coppe D
    Pediatrics; 1983 Jan; 71(1):120-4. PubMed ID: 6336835
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of bleeding in dialysis patients.
    Galbusera M; Remuzzi G; Boccardo P
    Semin Dial; 2009; 22(3):279-86. PubMed ID: 19573008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the biological balance between thromboxanes and prostacyclins in relation to the platelet-vessel wall interaction.
    Jørgensen KA
    Dan Med Bull; 1982 May; 29(4):169-97. PubMed ID: 6286257
    [No Abstract]   [Full Text] [Related]  

  • 13. Conjugated estrogens for the management of gastrointestinal bleeding secondary to uremia of acute renal failure.
    Heunisch C; Resnick DJ; Vitello JM; Martin SJ
    Pharmacotherapy; 1998; 18(1):210-7. PubMed ID: 9469696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of "prostacyclin-like" activity in the rat blood vessel: changes in prostacyclin production related to body weight.
    Horváth G; Benkö G
    Acta Physiol Hung; 1984; 63(1):21-7. PubMed ID: 6430032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclooxygenase inhibition with acetylsalicylic acid unmasks a role for prostacyclin in erythropoietin-induced hypertension in uremic rats.
    Rodrigue ME; Lacasse-M S; Larivière R; Lebel M
    Can J Physiol Pharmacol; 2005 Jun; 83(6):467-75. PubMed ID: 16049546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced prostacyclin synthesis in acute human kidney transplant rejection.
    Leithner C; Sinzinger H; Silberbauer K; Wolf A; Stummvoll HK; Pinggera W
    Proc Eur Dial Transplant Assoc; 1980; 17():424-8. PubMed ID: 7017684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure of salicylate to reduce inhibition of human venous prostacyclin in synthesis by conventional dose aspirin.
    Hanley SP; Hughes J
    Thromb Haemost; 1983 Feb; 49(1):51-2. PubMed ID: 6342201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of prostacyclin synthesis in cultured human arterial smooth muscle cells, venous endothelial cells and skin fibroblasts.
    Baenziger NL; Becherer PR; Majerus PW
    Cell; 1979 Apr; 16(4):967-74. PubMed ID: 110457
    [No Abstract]   [Full Text] [Related]  

  • 19. [The modification of the biosynthesis and effect of thromboxane A2 and prostacyclin by trapidil (Rocornal)].
    Block HU; Heinroth I; Giessler C; Pönicke K; Mentz P; Zehl U; Rettkowski W; Dunemann A; Förster W
    Biomed Biochim Acta; 1983; 42(2-3):283-99. PubMed ID: 6411078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thromboxane A2 and prostacyclin generation in the microvasculature of patients with atherosclerosis--effect of low-dose aspirin.
    Kyrle PA; Minar E; Brenner B; Eichler HG; Heistinger M; Marosi L; Lechner K
    Thromb Haemost; 1989 Jun; 61(3):374-7. PubMed ID: 2508252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.